Literature DB >> 275252

Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.

R C Reuben, P L Khanna, Y Gazitt, R Breslow, R A Rifkind, P A Marks.   

Abstract

Hexamethylenebisacetamide is a potent inducer of erythroid differentiation in murine erythroleukemia cells. A series of chemical compounds structurally related to hexamethylenebisacetamide were tested for inducing activity including polymethylene chains terminally substituted with various combinations of carboxylate, amino, amide, or sulfoxide groups. Effective "dimerization" of dimethyl sulfoxide through a linear polymethylene chain increases its inducing activity by a magnitude similar to that observed when N-methylacetamide is effectively dimerized in such a manner. It was found that all potent inducing agents possess both a hydrophilic and hydrophobic portion of the molecule, as well as a planar portion. All are Lewis bases, possessing a free electron pair available for hydrogen bonding. The polymethylene chain joining functional groups must be flexible and must be 5 to 6 carbon atoms in length to achieve maximal activity. Introduction of triple or double (cis or trans) bonds into the polymethylene chain does not alter activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 275252

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds.

Authors:  M Terada; H Fujiki; P A Marks; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

2.  Potent cytodifferentiating agents related to hexamethylenebisacetamide.

Authors:  R Breslow; B Jursic; Z F Yan; E Friedman; L Leng; L Ngo; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide.

Authors:  B A Conley; G F Sewack; M J Egorin; B Subramanyam; J G Page; C K Grieshaber
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Differentiation of Friend erythroleukemia cells induced by benzodiazepines.

Authors:  J K Wang; J I Morgan; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.

Authors:  P A Marks; R Breslow; R A Rifkind; L Ngo; R Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Organizational changes in chromatin at different malignant stages of Friend erythroleukemia.

Authors:  K E Leonardson; S B Levy
Journal:  Nucleic Acids Res       Date:  1980-11-25       Impact factor: 16.971

7.  Modification of lipophilic proteins in Friend erythroleukemia cells during their differentiation.

Authors:  M Semmel; E Delain
Journal:  Mol Biol Rep       Date:  1981-08-14       Impact factor: 2.316

8.  Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.

Authors:  B A Conley; M J Egorin; E G Zuhowski; V J Sinibaldi; D E Peterson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 9.  Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.

Authors:  P A Marks; R A Rifkind
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.